Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters

In March 2020, the first cases of the human coronavirus disease COVID-19 were registered in Kazakhstan. We isolated the SARS-CoV-2 virus from clinical materials from some of these patients. Subsequently, a whole virion inactivated candidate vaccine, QazCovid-in, was developed based on this virus. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhugunissov, Kuandyk, Zakarya, Kunsulu, Khairullin, Berik, Orynbayev, Mukhit, Abduraimov, Yergali, Kassenov, Markhabat, Sultankulova, Kulyaisan, Kerimbayev, Aslan, Nurabayev, Sergazy, Myrzakhmetova, Balzhan, Nakhanov, Aziz, Nurpeisova, Ainur, Chervyakova, Olga, Assanzhanova, Nurika, Burashev, Yerbol, Mambetaliyev, Muratbay, Azanbekova, Moldir, Kopeyev, Syrym, Kozhabergenov, Nurlan, Issabek, Aisha, Tuyskanova, Moldir, Kutumbetov, Lespek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503606/
https://www.ncbi.nlm.nih.gov/pubmed/34646246
http://dx.doi.org/10.3389/fmicb.2021.720437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503606/
https://www.ncbi.nlm.nih.gov/pubmed/34646246
http://dx.doi.org/10.3389/fmicb.2021.720437

Ejemplares similares